Bence-jones proteins immunological test system

Recombinant protein fragment of Human ABHD10 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human ABHD10 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human ABHD10&nbspwith&nbspN-terminal His 6 ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag.&nbsp &nbsp&nbsp Application Blocking agent and positive assay control using

Recombinant protein fragment of Human ABHD16B with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human ABHD17B with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

Recombinant protein fragment of Human ABHD17C with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen ACBD7 acyl-CoA binding domain containing 7, 10

PrEST Antigen ADAM8 ADAM metallopeptidase domain 8, 100ul UN

Recombinant protein fragment of Human ADAMTS10 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.

PrEST Antigen ADAMTSL3 ADAMTS-like 3, 100ul UN 1687 6.1 PG2

PrEST Antigen ADAMTSL3 ADAMTS-like 3, 100ul UN 1687 6.1 PG2

Recombinant protein fragment of Human AKAP9 with N-terminal His6ABP (ABP = Albumin Binding Protein derived from Streptococcal Protein G) fusion tag. Application Suitable as a blocking agent using corresponding antibodies.